Suppr超能文献

通过红细胞碳酸酐酶同工酶的选择性失活来确定骨石化表型。

The determination of osteopetrotic phenotypes by selective inactivation of red cell carbonic anhydrase isoenzymes.

作者信息

Conroy C W, Maren T H

出版信息

Clin Chim Acta. 1985 Nov 15;152(3):347-54. doi: 10.1016/0009-8981(85)90110-x.

Abstract

Red cell carbonic anhydrase isoenzyme activities (HCA-I and HCA-II) were quantitated in blood hemolysates of two female siblings affected with autosomal recessive osteopetrosis in addition to family members who were both obligate and potential heterozygotes as well as normal controls. Selective inactivation of red cell hemolysates with 20 mmol/l bromopyruvic acid (pH 7.5) for 50 min at 25 degrees C lead to a near quantitative removal of HCA-I activity without significant loss of HCA-II activity. Comparison of untreated hemolysate HCA activity with residual activity in bromopyruvate treated samples allowed determination of HCA-II/HCA-I activity ratios. Estimation of activity ratios was also attempted by use of the inhibitor I- which is known to discriminate between the two isoenzymes. Hemolysate HCA activity of the two affected individuals (homozygotes) was completely abolished by the procedure, consistent with an absence of the bromopyruvate resistant HCA-II isoenzyme in the red cells of these individuals. HCA-I activities were found to be elevated significantly above normal. Both parents (obligate heterozygotes) were found to have normal HCA-I activities and HCA-II activities 60-80% of normal. Computed HCA-II/HCA-I activity ratios fell into these ranges: 0 for homozygotes, 0.82-0.87 for obligate heterozygotes and 1.08-1.16 for normal controls. KI values for I- inhibition of hemolysate HCA activity gave 0.25-0.30 mmol/l, 0.9-1.5 mmol/l and 2.0 mmol/l for the three categories. These relations should prove useful in the screening of osteopetrotic phenotypes.

摘要

在两名患有常染色体隐性骨硬化症的女性同胞的血液溶血产物中,对红细胞碳酸酐酶同工酶活性(HCA - I和HCA - II)进行了定量分析,此外还对家族成员进行了分析,这些家族成员包括必然杂合子和潜在杂合子以及正常对照。在25摄氏度下,用20 mmol / l溴丙酮酸(pH 7.5)对红细胞溶血产物进行50分钟的选择性灭活,导致HCA - I活性几乎被定量去除,而HCA - II活性没有明显损失。将未处理的溶血产物HCA活性与经溴丙酮酸处理的样品中的残留活性进行比较,可以确定HCA - II / HCA - I活性比。还尝试通过使用已知能区分这两种同工酶的抑制剂I - 来估计活性比。该程序完全消除了两名受影响个体(纯合子)的溶血产物HCA活性,这与这些个体红细胞中不存在对溴丙酮酸有抗性的HCA - II同工酶一致。发现HCA - I活性显著高于正常水平。父母双方(必然杂合子)的HCA - I活性正常,HCA - II活性为正常的60 - 80%。计算得出的HCA - II / HCA - I活性比落入以下范围:纯合子为0,必然杂合子为0.82 - (此处原文似乎有误,应是0.82 - 0.87),正常对照为1.08 - 1.16。对于溶血产物HCA活性的I - 抑制作用,三类的KI值分别为0.25 - 0.30 mmol / l、0.9 - 1.5 mmol / l和2.0 mmol / l。这些关系在骨硬化症表型的筛查中应会很有用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验